Related Experiment Video

Updated: Jun 17, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Growth differentiation factor-15: a new biomarker in cardiovascular disease

Tibor Kempf1, Kai C Wollert

  • 1Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.

Herz
|December 22, 2009
PubMed

Insights

Growth Differentiation Factor-15 (GDF-15) is a key biomarker for cardiovascular disease. Elevated GDF-15 levels predict poor outcomes, independent of other markers, aiding in risk assessment and patient management.

Area of Science:

  • Biochemistry
  • Cardiology
  • Biomarkers

Background:

  • Growth Differentiation Factor-15 (GDF-15) is a stress-responsive cytokine.
  • It is increasingly recognized as a significant biomarker for cardiovascular dysfunction and disease.
  • Elevated GDF-15 levels are observed across the cardiovascular disease spectrum.

Purpose of the Study:

  • To highlight the emerging role of GDF-15 as a biomarker in cardiovascular disease.
  • To discuss the prognostic value of GDF-15 in various cardiovascular conditions.
  • To explore the potential clinical applications of GDF-15 in patient management.

Main Methods:

  • The study reviews existing literature and clinical data on GDF-15.
  • It analyzes the association of GDF-15 with cardiovascular outcomes.
  • Comparisons are made with established biomarkers like NT-proBNP and troponin.

Main Results:

  • Elevated circulating GDF-15 levels identify high-risk individuals with conditions ranging from stable coronary artery disease to heart failure.
  • The prognostic information from GDF-15 is independent of traditional risk factors and other biomarkers.
  • GDF-15 shows potential in guiding treatment strategies, such as invasive approaches in acute coronary syndrome and monitoring heart failure treatment.

Conclusions:

  • GDF-15 is a valuable prognostic biomarker in cardiovascular disease.
  • Its independent predictive power offers insights beyond current risk assessment tools.
  • Further prospective studies are needed to integrate GDF-15 into risk prediction and therapeutic management strategies.

More Related Videos

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions12:48

Induction of Endothelial Differentiation in Cardiac Progenitor Cells Under Low Serum Conditions

Published on: January 7, 2019

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...